AI assistant
Adicet Bio, Inc. — Director's Dealing 2021
May 21, 2021
34412_dirs_2021-05-21_1315ee43-9a76-4e5d-bd03-7af040ec1765.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-05-19
Reporting Person: Schor Chen (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-19 | Common Stock | S | 6872 | $13.4232 | Disposed | 90421 | Indirect |
| 2021-05-19 | Common Stock | S | 612 | $13.7277 | Disposed | 89809 | Indirect |
| 2021-05-19 | Common Stock | S | 8249 | $13.4232 | Disposed | 108533 | Indirect |
| 2021-05-19 | Common Stock | S | 733 | $13.7277 | Disposed | 107800 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.69 to $13.66, inclusive.
F3: Represents shares held directly by an irrevocable family trust having an independent trustee.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.69 to $13.79, inclusive.
F5: Represents shares held directly by an irrevocable family trust having an independent trustee.